Business Description
Jacobson Pharma Corp Ltd
ISIN : KYG677291067
Share Class Description:
HKSE:02633: Shs Reg STotal Employee Number:
1,768Compare
Compare
Traded in other countries / regions
02633.Hong Kong IPO Date
2016-09-21Description
Jacobson Pharma Corp Ltd and its subsidiaries are principally engaged in the development, production, marketing, and sale of essential medicines and specialty drugs to both the public and private sectors. The Group's essential medicines portfolio covers various therapeutic categories such as cardiovascular, central nervous system, gastrointestinal, antidiabetic, respiratory, anti-infective, etc.; and the specialty drugs portfolio comprises biosimilars, oncology medications, and orphan drugs. Additionally, its veterinary health division supports veterinarians and veterinary clinics with several products in different therapeutic classes and pharmaceutical forms. Geographically, the Group derives maximum revenue from Hong Kong, and the rest from Macau, the Chinese Mainland, and other regions.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.41 | |||||
Equity-to-Asset | 0.65 | |||||
Debt-to-Equity | 0.39 | |||||
Debt-to-EBITDA | 2.32 | |||||
Interest Coverage | 11.65 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.38 | |||||
Beneish M-Score | -2.39 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6 | |||||
3-Year EBITDA Growth Rate | 2 | |||||
3-Year EPS without NRI Growth Rate | 11.1 | |||||
3-Year FCF Growth Rate | -31.2 | |||||
3-Year Book Growth Rate | -6.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 13.97 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 8.22 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 47.39 | |||||
9-Day RSI | 47.96 | |||||
14-Day RSI | 46.89 | |||||
3-1 Month Momentum % | -5.31 | |||||
6-1 Month Momentum % | -15.75 | |||||
12-1 Month Momentum % | -26.21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.37 | |||||
Quick Ratio | 0.86 | |||||
Cash Ratio | 0.52 | |||||
Days Inventory | 143.67 | |||||
Days Sales Outstanding | 37.68 | |||||
Days Payable | 18.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 9.33 | |||||
Dividend Payout Ratio | 0.65 | |||||
3-Year Dividend Growth Rate | 21.2 | |||||
Forward Dividend Yield % | 9.09 | |||||
5-Year Yield-on-Cost % | 29.16 | |||||
3-Year Average Share Buyback Ratio | -1.6 | |||||
Shareholder Yield % | 1.6 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 43.19 | |||||
Operating Margin % | 22.79 | |||||
Net Margin % | 19.22 | |||||
EBITDA Margin % | 25.06 | |||||
FCF Margin % | 12.25 | |||||
OCF Margin % | 20.92 | |||||
ROE % | 12.92 | |||||
ROA % | 8.43 | |||||
ROIC % | 9.91 | |||||
3-Year ROIIC % | -7.53 | |||||
ROC (Joel Greenblatt) % | 21.74 | |||||
ROCE % | 13.44 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 6.85 | |||||
Forward PE Ratio | 6.51 | |||||
PE Ratio without NRI | 6.85 | |||||
Shiller PE Ratio | 7.96 | |||||
Price-to-Owner-Earnings | 10.46 | |||||
PEG Ratio | 1.76 | |||||
PS Ratio | 1.32 | |||||
PB Ratio | 0.89 | |||||
Price-to-Tangible-Book | 1.1 | |||||
Price-to-Free-Cash-Flow | 10.79 | |||||
Price-to-Operating-Cash-Flow | 6.31 | |||||
EV-to-EBIT | 6.75 | |||||
EV-to-EBITDA | 6.75 | |||||
EV-to-Revenue | 1.69 | |||||
EV-to-FCF | 13.82 | |||||
Price-to-GF-Value | 1.22 | |||||
Price-to-Projected-FCF | 0.41 | |||||
Price-to-Median-PS-Value | 1.2 | |||||
Price-to-Graham-Number | 0.58 | |||||
Earnings Yield (Greenblatt) % | 14.81 | |||||
FCF Yield % | 9.28 | |||||
Forward Rate of Return (Yacktman) % | 21.08 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jacobson Pharma Corp Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 1,569.463 | ||
| EPS (TTM) (HK$) | 0.151 | ||
| Beta | 0.1473 | ||
| 3-Year Sharpe Ratio | 0.46 | ||
| 3-Year Sortino Ratio | 1.07 | ||
| Volatility % | 13.07 | ||
| 14-Day RSI | 46.89 | ||
| 14-Day ATR (HK$) | 0.016448 | ||
| 20-Day SMA (HK$) | 1.04325 | ||
| 12-1 Month Momentum % | -26.21 | ||
| 52-Week Range (HK$) | 0.98 - 1.53 | ||
| Shares Outstanding (Mil) | 2,000.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jacobson Pharma Corp Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jacobson Pharma Corp Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| HKD 0.047500 Cash Dividend | 2026-09-07 | In 5 days | ||
| HKD 0.042500 Cash Dividend | 2025-12-01 | 1.35 (-0.74%) | ||
| HKD 0.055000 Cash Dividend | 2025-08-11 | 1.65 (-0.60%) | ||
| HKD 0.060000 Cash Dividend | 2025-08-11 | 1.65 (-0.60%) | ||
| HKD 0.035000 Cash Dividend | 2025-02-25 | 1.26 (+1.61%) | ||
| HKD 0.030000 Cash Dividend | 2024-09-03 | 0.61 (+0.00%) |
Show
Entries
Jacobson Pharma Corp Ltd Frequently Asked Questions
What is Jacobson Pharma Corp Ltd(HKSE:02633)'s stock price today?
The current price of HKSE:02633 is HK$1.03. The 52 week high of HKSE:02633 is HK$1.53 and 52 week low is HK$0.98.
When is next earnings date of Jacobson Pharma Corp Ltd(HKSE:02633)?
The next earnings date of Jacobson Pharma Corp Ltd(HKSE:02633) is .
Does Jacobson Pharma Corp Ltd(HKSE:02633) pay dividends? If so, how much?
The Dividend Yield %  of Jacobson Pharma Corp Ltd(HKSE:02633) is 9.33% (As of Today), Highest Dividend Payout Ratio of Jacobson Pharma Corp Ltd(HKSE:02633) was 0.65. The lowest was 0.07. And the median was 0.4. The  Forward Dividend Yield % of Jacobson Pharma Corp Ltd(HKSE:02633) is 9.09%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Jacobson Pharma Corp Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers